Xin Hee (SHE:003016) leased out a factory building to an artificial intelligence company in Xiamen, China, according to a Thursday filing with the Shenzhen bourse.
The lease to Xiamen Qiannianjun Artificial Intelligence Technology, worth a total of 6.4 million yuan, is valid from June 1, 2026, to Nov. 23, 2030.
Caliway Biopharmaceuticals (TPE:6919) completed its U.S. FDA IND submission for a Phase 3b long-term follow-up study of its abdominal subcutaneous fat reduction drug, according to a Wednesday Taiwan Exchange filing.The study, dubbed CBL-0303, is designed to evaluate long-term safety and maintenance of efficacy of the drug called CBL-514, before the trail.It is expected to enroll around 300 participants in the United States. The protocol also includes an optional re-treatment phase for eligible patients, the filing said.
Tansun Technology Co (SHE:300872) invested 100 million yuan in the Hongma Multidimensional Fund as a limited partner.After the transaction, the fund will have a total committed capital of 309 million yuan, giving the company a 32.36% stake, according to a Thursday filing with the Shenzhen bourse.Shares of the information technology company closed 2% lower Thursday.
Guangdong Sunwill Precising Plastic (SHE:002676) plans to raise proceeds worth up to 242.3 million yuan through a share placement, according to a Shenzhen bourse filing on Thursday.The proceeds will be used for the upgrade of an automated intelligent manufacturing base for fan blades and the construction of a high-performance modified composite materials plant, as well as for the supplementation of the company's working capital.The Chinese plastic air-conditioning fan blades producer's shares rose 3% at the close.